•  
  •  
  •  
  •  

2025-12-23 11:00:16

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial

Keywords Selected:  ICC

Stock Report

  • India Finsec Ltd to surrender NBFC-ICC CoR
  • Ion Exchange India Ltd gets favorable verdict in arbitration claim filed against it by Ethigen Inc
  • IndusInd Bank Scores Big at 'Anthem Companion Programme' of ICC Men's Cricket World Cup 2023
  • ICC and Mphasis announce strategic digital partnership at the ICC Men's Cricket World Cup 2023
  • Airtel Delivers Best Mobile Live Video Streaming Experience in M A Chidambaram Stadium, Chennai
  • IndusInd Bank announces multi-year global partnership with International Cricket Council
  • Federal Bank Hosted a Cricket Extravaganza: ICC Men's Cricket World Cup Trophy Tour Arrived with a Bang!
  • Kiri Industries' DyStar stake valued at US$ 603.80 Mn by SICC
  • ZEE Entertainment and Disney Star sign strategic licensing agreement for exclusive TV rights of ICC men's events

Latest Post

  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024